Pharmacy

Latest News

FDA approves first biosimilar product for retinal diseases
Making the grade: FDA approves first biosimilar product for retinal diseases

November 1st 2021

The FDA has given its approval to Byooviz (ranibizumab-nuna, SB11, Samsung Bioepis Co Inc and Biogen Inc), a biosimilar referencing Lucentis (ranibizumab, Genentech).

Advancement in TED treatment is a bright spot
Advancement in TED treatment is a bright spot

June 30th 2021

Comparable conscious sedation methods address individual patient needs
Comparable conscious sedation methods address individual patient needs

April 14th 2021

Investigators uncover health care disparities among US patients
Investigators uncover health care disparities among US patients

April 2nd 2021

Investigators zoom in on future of dry eye treatment
Investigators zoom in on future of dry eye treatment

March 2nd 2021

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.